Innovative Fusion Superkine and Focused Ultrasound Offer New Hope for Glioblastoma Treatment
Innovative fusion superkine combined with focused ultrasound offers a promising noninvasive therapy for glioblastoma, targeting tumor cells and boosting immune response through advanced delivery techniques.
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a groundbreaking approach to combat glioblastoma (GBM), one of the most aggressive and deadly brain cancers with no current cure. This innovative strategy combines a novel fusion superkine (FSK), which includes dual therapeutic cytokines, with advanced focused ultrasound technology to deliver the treatment safely across the blood-brain barrier (BBB). The FSK integrates two potent molecules: a next-generation IL-24S (superkine) that induces tumor cell death, and IL-15, which activates important immune cells, enhancing the immune response against cancer cells. In preclinical studies involving glioblastoma models, this combination has demonstrated superior tumor regression and increased survival rates compared to individual cytokines, inspiring hope for more effective treatments.
The delivery method involves creating an adenovirus vector expressing the FSK, which is then transported into the brain using focused ultrasound and microbubbles (FUS-DMB). This technique temporarily and safely opens the BBB, allowing the therapeutic virus to reach tumor sites without invasive surgery—a significant advancement in brain cancer therapy. The researchers aim to expand this approach into clinical trials by 2026, with the goal of providing a noninvasive option for treating primary and secondary brain tumors.
This research marks a significant milestone in immunotherapy and virotherapy fields, addressing the challenges of drug delivery and immune suppression typical of GBM. Experts believe this technology could revolutionize how brain tumors are treated by not only destroying existing tumors but also fostering a long-lasting immune response to prevent recurrence. As the team continues to refine their methods, future studies will explore the potential applications across various tumor types, aiming to ultimately improve patient outcomes worldwide.
Source: https://medicalxpress.com/news/2025-06-fusion-superkine-focused-ultrasound-enable.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Finds Telehealth Prescriptions for ADHD Do Not Increase Risk of Substance Use Disorders
A groundbreaking study shows that prescribing ADHD medications via telehealth does not increase the risk of substance use disorders, supporting its safe use for treatment accessibility.
Link Between Drinking Water, Food, and PFAS Exposure in California Adults
A new study from Boston University reveals that drinking water, seafood, eggs, and brown rice contribute to PFAS exposure in California adults, emphasizing the need for regulatory action and consumer awareness to reduce health risks.
Enhanced Brain Imaging Benchmark Improves Classification of Alzheimer's Disease Changes
Researchers from USC have developed a new brain imaging benchmark using tau PET scans that improves classification of Alzheimer's disease-related changes, highlighting the importance of diverse populations in research.
Breakthrough in Trauma Care: Rapid Identification and Targeted Treatment Using Molecular Footprints
Rutgers researchers have unveiled a groundbreaking method to rapidly identify and target injury sites in the body, promising faster and more precise trauma treatments. Leveraging the body's molecular response to injury, this innovative approach could significantly improve emergency care outcomes.